Speakers

Expand/Collapse

Chandra Webb
Senior Director, Drug Product Regulatory Strategy
Pfizer

Day Two

Thursday, April 14 2022

2:45 pm | Roundtable Discussion: Understanding Process Control Considerations to Support Regulatory Submissions

Shrirang Karve
Senior Director, Drug Delivery & Formulation Development
Sanofi

John Champagne
Senior Applications Scientist & Northeast Regional Manager
Wyatt Technology

Day Two

Thursday, April 14 2022

4:00 pm | Quality Attributes and Extended Characterization of Gene Vectors Using Light Scattering

George Dakwar, Ph.D.
Senior Scientist Drug Product Development
eTheRNA

Day One

Wednesday, April 13 2022

5:15 pm | Beyond the Liver: the CMC development journey of the first systemic LNP-mRNA

Richard Gray
Business Development Director
Particle Works

Pre-Conference Bootcamp Day

10:15 am | Automated & Scalable Microfluidic Platforms to Accelerate LNP Formulation Screening, Process Optimization & Production

Ben Peacock
Applications Manager
NanoFCM

Day Two

Thursday, April 14 2022

10:00 am | Assessment of LNP Quality and Encapsulation Efficiency by Nano-flow Cytometry

Xudong Yuan
Chief Executive Officer
ACON Pharma

Pre-Conference Bootcamp Day

11:45 am | How Did LNPs Become the Most Popular Delivery Vehicle Overnight & What’s Next?

Dushyant Varshney
Chief Technology Officer
Arcturus Therapeutics

Day Two

Thursday, April 14 2022

5:00 pm | Discussing Global Technology Transfer and Commercialization of Next-Gen mRNA Therapeutics & Vaccines

Gilles Besin
Vice President, Head, Discovery Research
Affinivax Inc.

Day One

Wednesday, April 13 2022

8:30 am | Chair’s Opening Remarks

Luis Brito
Vice President, Delivery Platform
Beam Therapeutics

Day One

Wednesday, April 13 2022

8:45 am | Roundtable Discussion:In-Depth Discussion of the LNP Landscape & Future Opportunities

Anthony Barry
Executive Director, Biotherapeutics and Technologies
Pfizer

Day One

Wednesday, April 13 2022

2:45 pm | Discussing the Lessons Learnt From the SARS-CoV-2 Vaccine & Current LNPs & Evaluating the Future Directions for this Novel Technology

Heinrich Haas
Vice President, RNA Formulation & Drug Delivery
BioNTech

Day Two

Thursday, April 14 2022

9:30 am | What’s Next? Next Generation LNPs to Support Novel Therapies With Collaboration

Sharon Wang
SVP of Technical Development
Ultragenyx Pharmaceuticals

Day Two

Thursday, April 14 2022

10:15 am | Panel Discussion: Comparing & Evaluating Different Mixing Techniques With Respect to Scalability, Stability & Cost Effectiveness

Mostafa Nakach
Head of Formulation & Process Development
Sanofi

Day Two

Thursday, April 14 2022

12:15 pm | Providing the Optimal Self-Assembly of Lipid Nanoparticles in a Ring Micromixer

Pre-Conference Bootcamp Day

3:00 pm | Maximizing the Long-Term Stability of LNPs & Scaling Up LNP Manufacturing Effectively

Aalok Shah
Director, Formulation & Drug Delivery
Strand Therapeutics

Day Two

Thursday, April 14 2022

10:15 am | Panel Discussion: Comparing & Evaluating Different Mixing Techniques With Respect to Scalability, Stability & Cost Effectiveness

Jane Wang
Head of LNP Formulation
Tessera Therapeutics

Day One

Wednesday, April 13 2022

8:45 am | Roundtable Discussion:In-Depth Discussion of the LNP Landscape & Future Opportunities

Sumit Luthra
Head Global CMC Drug Product Development, mRNA CoE
Sanofi

Day Two

Thursday, April 14 2022

2:45 pm | Roundtable Discussion: Understanding Process Control Considerations to Support Regulatory Submissions

Vivek Garripelli
Associate Director
Ultragenyx Pharmaceuticals

Day Two

Thursday, April 14 2022

5:30 pm | Asking the Question: How to Scale up LNPs With Control From Lab to GMP?

Mohamed Elsayed
Senior Research Fellow, Biotechnology Discovery Research
Eli Lilly & Co

Day One

Wednesday, April 13 2022

8:45 am | Roundtable Discussion:In-Depth Discussion of the LNP Landscape & Future Opportunities

Allen Horhota
Senior Director, Head of Delivery
Orna Therapeutics

Day Two

Thursday, April 14 2022

3:30 pm | oRNA: A Superior Coding RNA Payload for LNP Processing & Scale-up

Dan Duda
Associate Professor
Harvard Medical School

Day One

Wednesday, April 13 2022

3:15 pm | Using LNPs for mRNA-based Therapy of Liver Cancer

Apoorva Sarode
Senior Technology Scientist
Genentech

Day One

Wednesday, April 13 2022

5:30 pm | Utilizing PEGylation as a Strategy to Improve Nanoparticle-based Drug & Gene Delivery

Daniel Shores
Partner
Rothwell Figg Ernst & Manbeck

Day Two

Thursday, April 14 2022

9:00 am | Opening Address: Navigating the IP Landscape for Lipid Nanoparticle Technology in the mRNA Space

Dimitrios Lamprou
Reader for Pharmaceutical Engineering
Queen’s University Belfast

Day Two

Thursday, April 14 2022

11:45 am | Assessing the Effects of Microfluidic Operating Parameters to Increase LNP Scalability & Stability

Pre-Conference Bootcamp Day

11:45 am | How Did LNPs Become the Most Popular Delivery Vehicle Overnight & What’s Next?

James Dahlman
Associate Professor
Georgia Institute of Technology

Day One

Wednesday, April 13 2022

12:15 pm | Reviewing the Ability to Test Thousands of Nanoparticles in vivo Using DNA Barcodes

Thomas Axel Haag
Chief Executive Officer
AexeRNA Therapeutics

Day One

Wednesday, April 13 2022

3:45 pm | Molecular Design Principles for Lipid Nanoparticle Mediated Delivery of mRNA

Kuntal Ganguly
Head of Research & Development
Venus Remedies

Day One

Wednesday, April 13 2022

10:15 am | Delivering LNP Beyond the Liver: Enhancing Formulation of LNPs With Target Destination in Mind

Jayesh Kulkarni
Chief Scientific Officer
NanoVation

Day One

Wednesday, April 13 2022

9:45 am | Discussing the Composition of LNPs With Respect to Their Efficacy & Function

P.J. Brooks
Program Director
NCATS, NIH

Day One

Wednesday, April 13 2022

8:45 am | Roundtable Discussion:In-Depth Discussion of the LNP Landscape & Future Opportunities

Rakesh Dixit
President, CEO
Bionavigen

Day One

Wednesday, April 13 2022

4:45 pm | Refining the Balance Between Dosing & Toxicity With Respect to Formulation

Rui Zhang
Associate Director, LNP Formulation
Tessera Therapeutics

Day One

Wednesday, April 13 2022

8:45 am | Roundtable Discussion:In-Depth Discussion of the LNP Landscape & Future Opportunities

Tom Anchordoquy
Professor
Skaggs School of Pharmaceutical Sciences

Day One

Wednesday, April 13 2022

12:45 pm | Addressing the Key Challenge Associated With LNPs – Enhancing Long Term Stability to Maximize Drug Product Quality & Shelf-Life

Zohreh Amoozga
Principal Scientist
Sanofi

Day Two

Thursday, April 14 2022

8:50 am | Chair’s Opening Remarks

Nishan Shah, Ph.D.
Manager, Drug Product Development
Arranta Bio

Day One

Wednesday, April 13 2022

1:15 pm | Flexible LNP Formulation, Process Development & Manufacturing Solutions

Rahul Keswani
Director, Technical Services
Exelead

Day One

Wednesday, April 13 2022

10:45 am | Smoothing Your LNP Tech Transfer & Establishing Robust CDMO Partnerships with Exelead

Lloyd Jeffs
Senior Director, Pharmaceutical Development
Precision Nanosystems

Day Two

Thursday, April 14 2022

12:45 pm | Translating the Discovery and design of RNA-Based LNP into Scalable Genomic Medicines

Dai Hayward
Chief Executive Officer
Micropore Technologies

Day Two

Thursday, April 14 2022

10:15 am | Panel Discussion: Comparing & Evaluating Different Mixing Techniques With Respect to Scalability, Stability & Cost Effectiveness